Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.40
+0.13 (2.47%)
At close: Oct 31, 2024, 4:00 PM
5.47
+0.07 (1.30%)
After-hours: Oct 31, 2024, 6:33 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $367.65 million as of October 31, 2024. Its market cap has decreased by -69.50% in one year.
Market Cap
367.65M
Enterprise Value
52.12M
1-Year Change
-69.50%
Ranking
Category
Stock Price
$5.40
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $367.65M, a decrease of -65.61%. That is a compound annual growth rate of -31.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 358.80M | -63.90% |
Dec 29, 2023 | 993.90M | -59.40% |
Dec 30, 2022 | 2.45B | 128.98% |
Jan 7, 2022 | 1.07B | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ZimVie | 385.45M |
Voyager Therapeutics | 382.82M |
Nyxoah | 368.30M |
Anika Therapeutics | 364.89M |
ClearPoint Neuro | 362.88M |
Alpha Teknova | 358.73M |
Enhabit | 358.52M |
DocGo | 355.04M |